Efficacy and Safety of OPL-0301 Compared to Placebo in Adults With Post-Myocardial Infarction (MI)

Summary

Study OPL-0301-201 is intended to generate efficacy and safety data of OPL-0301 in participants with post-myocardial infarction (MI) left ventricular dysfunction (LVD)

Timeline

Start

2022-09

Primary completion

2024-08

Completion

2024-11

Outcome

Outcome not reported

Stopped (Enrollment): “Withdrawn based on business decision, no participants enrolled”

Drugs

Indications